NFG
VIVO

Next Financial Group’s Meridian Bioscience Inc VIVO Stock Holding History

Next Financial Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-900
Closed -$18K – 1897
2015
Q4 		$18K Sell
900
-100
-10% -$1.92K 0.01% 975
2015
Q3 		$17K Hold
1,000
– – 0.01% 1026
2015
Q2 		$18K Hold
1,000
– – 0.01% 1050
2015
Q1 		$19K Buy
+1,000
New +$18.5K 0.01% 1019

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Next Financial Group's VIVO Position: Q1 2016 in Review

Next Financial Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2016, closing a stake of 900 shares — an estimated $18K sold.

Next Financial Group first reported a position in VIVO in Q1 2015 and held it in 4 quarters. The position peaked at $19K in Q1 2015. 172 funds tracked by Wall St. Rank hold VIVO as of Q1 2016.

  • Next Financial Group reported no remaining Meridian Bioscience Inc position as of Q1 2016 after selling out during the quarter.
  • Next Financial Group sold 900 Meridian Bioscience Inc shares in Q1 2016, an estimated $18K.
  • Next Financial Group first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 4 quarters.
  • Next Financial Group's Meridian Bioscience Inc position peaked at $19K in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2016.

Based on Next Financial Group's 13F filing for Q1 2016, filed 20 Apr 2016.